← Back to headlines
RBC Capital Sustains Outperform Rating on Wave Life Sciences
RBC Capital has reiterated its 'Outperform' rating for Wave Life Sciences (WVE), indicating a continued positive outlook on the biotechnology company's stock.
12 Apr, 21:18 — 12 Apr, 21:18
Sources
Showing 1 of 1 sources
Related Stories
Heirs Life Assurance Appoints Pastor Jerry Eze as Independent Non-Executive Director
31m ago
Nigerian Finance Minister Queries NAICOM Over Insurance Recapitalisation Fees
38m ago
FM Sitharaman Assures No UPI Charges for Consumers as Parliament Clears Tax Bill
2h ago
Rethinking Roth IRAs for Retirement Security
3h ago